Severe architectural disorder is a potential pitfall in the diagnosis of small melanocytic lesions

Journal of Cutaneous Pathology

Volumn 37, Issue 8, 2010, Pages 860-865

  Torres Cabala, Carlos A ^a   Plaza, Jose A ^a   Diwan, A Hafeez ^a   Prieto, Victor G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLASSIFICATION; DYSPLASTIC NEVUS; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PIGMENTED NEVUS; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DYSPLASTIC NEVUS SYNDROME; FEMALE; HUMANS; MALE; MIDDLE AGED; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 77953435841     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2009.01377.x     Document Type: Article

References (19)

1. Elder DE. Precursors to melanoma and their mimics: nevi of special sites. Mod Pathol 2006 19 (Suppl. 2 S4.
2. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997 277 (18 1439.
3. Shea CR, Vollmer RT, Prieto VG. Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol 1999 30 (5 500.
4. Shors AR, Kim S, White E, et al. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol 2006 155 (5 988.
5. Arumi-Uria M, McNutt NS, Finnerty B. Grading of atypia in nevi: correlation with melanoma risk. Mod Pathol 2003 16 (8 764.
6. Clark WH, Jr., Tucker MA. Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma. Hum Pathol 1998 29 :8.
7. Bergman R, Katz I, Lichtig C, Ben-Arieh Y, Moscona AR, Friedman-Birnbaum R. Malignant melanomas with histologic diameters less than 6 mm. J Am Acad Dermatol 1992 26 : 462.
8. Annessi G, Cattaruzza MS, Abeni D, et al. Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol. 2001 45 :77.
9. Wick MR, Patterson JW. Cutaneous melanocytic lesions: selected problem areas. Am J Clin Pathol 2005 124 (Suppl. S52.
10. Clark WH, Jr. Malignant melanoma in situ. Hum Pathol 1990 21 :1197.
11. Braun-Falco M, Hein R, Ring J, McNutt NS. Histopathological characteristics of small diameter melanocytic naevi. J Clin Pathol 2003 56 :459.
12. Urso C. Atypical histologic features in melanocytic nevi. Am J Dermatopathol 2000 22 :391.
13. Barnhill RL, Roush GC, Duray PH. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol 1990 21 :51.
14. Piepkorn M, Meyer LJ, Goldgar D, et al. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989 20 :407.
15. Pozo L, Naase M, Cerio R, Blanes A, Diaz-Cano SJ. Critical analysis of histologic criteria for grading atypical (dysplastic) melanocytic nevi. Am J Clin Pathol 2001 115 :194.
16. Anonymous. Diagnosis and treatment of early melanoma. NIH Consensus Development Conference. January 27-29, 1992. Consensus Statement/NIH Consensus Development Conference 1992 10: 1.
17. Anonymous. NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA 1992 268 :1314.
18. Culpepper KS, Granter SR, McKee PH. My approach to atypical melanocytic lesions. J Clin Pathol 2004 57 :1121.
19. Khalifeh I, Taraif S, Reed JA, Lazar AF, Diwan AH, Prieto VG. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ. Am J Surg Pathol 2007 31 :1130.